We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Beam Therapeutics Inc
96 own
24 watching
Current Price
$25.98
$-0.31
(-1.18%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,013.36M
52-Week High
49.5
52-Week Low
20.84000
Average Volume
0.59M
Dividend Yield
--
P/E Ratio
--
Market Capitalization2,013.36M52-Week High49.552-Week Low20.84000Average Volume0.59MDividend Yield--P/E Ratio--What does the Beam Therapeutics Inc do?
Beam Therapeutics Inc. is a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases. Beam Therapeutics Inc.principal executive offices are located at 26 Landsdowne Street, 2nd Floor, Cambridge, MA 02139
Read More
How much money does Beam Therapeutics Inc make?
News & Events about Beam Therapeutics Inc.
Zolmax
1 year ago
Beam Therapeutics Inc. (NASDAQ:BEAM Get Rating) has earned an average recommendation of Moderate Buy from the eleven research firms that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating on ...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a fireside chat during the Guggenheim 2023 ...
Zolmax
2years ago
Beam Therapeutics Inc. (NASDAQ:BEAM Get Rating) CFO Terry-Ann Burrell sold 47,195 shares of the companys stock in a transaction that occurred on Wednesday, January 18th. The stock was sold at an average price of $45.14, for a total value of $2,130,382.30. Following the transaction, the chief ...
Zolmax
2years ago
Beam Therapeutics Inc. (NASDAQ:BEAM Get Rating) insider Giuseppe Ciaramella sold 51,015 shares of the firms stock in a transaction on Monday, December 12th. The shares were sold at an average price of $42.70, for a total value of $2,178,340.50. Following the completion of the sale, the insider now ...
Globe Newswire
2years ago
Data from ESCAPE-1 and ESCAPE-2 Approaches to Be Presented During Poster Sessions at the 64th ASH Annual Meeting and ExpositionCAMBRIDGE, Mass., Dec. 10, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base ...
Frequently Asked Questions
Frequently Asked Questions
What is Beam Therapeutics Inc share price today?
Can Indians buy Beam Therapeutics Inc shares?
How can I buy Beam Therapeutics Inc shares from India?
Can Fractional shares of Beam Therapeutics Inc be purchased?
What are the documents required to start investing in Beam Therapeutics Inc stocks?
What is today’s traded volume of Beam Therapeutics Inc?
What is today’s market capitalisation of Beam Therapeutics Inc?
What is the 52-Week High and Low Range of Beam Therapeutics Inc?
What percentage is Beam Therapeutics Inc down from its 52-Week High?
What percentage is Beam Therapeutics Inc up from its 52-Week Low?
Current Price
$25.98
$-0.31
(-1.18%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.